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ABSTRACT
Objective: The present study was aimed to develop a pH-triggered in situ gel for local release of lidocaine hydrochloride (lidocaine HCL) in the buccal 
cavity to improve the anesthetic effect of this amino amide drug which has very high water solubility. The formulations were introduced to the oral 
cavity as a spray to improve compliance and for easier administration.
Methods: In this work, two grades of carbopol (934 and 940)-based in situ gel spray were designed. The formulations containing lidocaine HCl 5% 
were prepared by mixing different concentrations of carbopol with xanthan gum. Eight formulations were investigated and evaluated for gelation 
capacity, spray angle, volume of solution delivered per each actuation, rheological properties, and release kinetic model. Similarity factor (f2) was used 
for the comparison of dissolution profiles.
Results: The prepared formulations undergo gelation after it had been actuated to the buccal cavity as a spray solution. The results showed that, as 
the concentration of polymer was increased, the release of drug decreased and the viscosity increased for both grades. The spray angle and volume 
of solution delivered per each actuation varied according to the composition of each formulation. The in situ gel containing 0.3% carbopol 934 and 
0.2% xanthan gum regarded as a better candidate which had a good gelation and release property compared to other formulations. Drug release from 
optimized in situ gel spray followed Korsmeyer–Peppas model and was mediated by Fickian diffusion mechanism.
Conclusion: Lidocaine HCl-loaded pH-sensitive in situ gel was successfully developed using carbopol 934 as polymer to be applied to the buccal cavity 
as spray solution for more effective anesthetic effect and painless treatment.
Keywords: Lidocaine Hydrochloride, Carbopol, In situ gel.
INTRODUCTION
The development of in situ gel systems has received considerable 
attention over the past few years. This interest has been sparked by the 
advantages shown by in situ-forming polymeric delivery systems such 
as ease of administration and reduced frequency of application, as well 
as improved patient compliance and comfort [1].
In situ gelling systems are liquid at room temperature but undergo 
gelation when they come into contact with body fluids or on change 
in pH. In contrast to hard gels, they can be easily applied in liquid form 
to the site of drug absorption. At the site of drug absorption, they swell 
to form a hard and bioadhesive gel that is capable of prolonging the 
residence time of the active substance.
Both natural and synthetic polymers can be used for the production of 
in situ gels, whose gelation can be triggered due to one or combination 
of different stimuli such as pH change, temperature modulation, and/or 
ionic crosslinking. It can be administered through different routes such 
as oral, ocular, rectal, vaginal, injectable, and intraperitoneal routes [2-4].
A promising in situ gel system is a pH-sensitive in situ forming gel which 
can undergo gelation based on change in pH as the sole physiological 
stimulus. All the pH-sensitive polymers contain pendant acidic or basic 
groups that can either accept or release protons in response to changes 
in environmental pH. Polymers with a large number of ionizable groups 
are known as polyelectrolytes. Swelling of these polymers increases 
as the external pH increases in the case of weakly acidic (anionic) 
group-rich polymer but decreases if the polymer contains weakly basic 
(cationic) groups. Most of anionic pH-sensitive polymers are based 
on polyacrylic acid (Carbopol®, carbomer) or its derivatives and are 
present as solution at acidic pH but converted to viscous gel on raise 
in the pH [5-7].
The buccal drug delivery system has many advantages over the 
conventional and systemic formulation majority. It helps in enhancing 
the bioavailability through bypassing the first-pass metabolism effect, 
the mucosal surface better absorption, and prolonged resident time. 
Among the various transmucosal sites available, mucosa of the buccal 
cavity was found to be the most convenient and easily approachable 
site for the delivery of the therapeutic agent for both local and systemic 
deliveries [8].
The design of oral sprays is usually a logical choice to improve patient’s 
compliance. In addition to that, the release of the medicament can be 
rapid in the form of micro-sized droplets in the oral cavity to be absorbed 
by buccal mucosa. This can result in a direct and rapid dispersion of a 
solution of the active agent over a large portion of the oral mucosa for 
better absorption of the active agent through the mucosal barrier [9].
Topical anesthetics are useful medicines during dental treatment, 
as they reduce dental phobia, especially in children, by mitigating 
discomfort and pain [10].
The mean of the administration of local anesthetic, namely injection, 
can cause fear and anxiety during dental treatment. The pain and 
discomfort resulting from injection can be minimized by a variety 
of techniques. These include appropriate behavior management 
techniques, altering the pH and temperature of the anesthetic solution 
and injecting the solution at a reduced rate [11].
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i11.28492
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On the other hand, topical anesthetic gels are easy to apply, but they 
possess some drawbacks such as a tendency to spread to other areas 
and lower retention in plaque area. Therefore, these gels can cause 
numbness of lips, tongue, and cheeks and have a bigger chance of 
accidental swallowing of the gel. To improve the residence time, in situ 
gels show promising effect [12].
Lidocaine is the prototype amino amide, local anesthetics and has been 
in use for many years. In dentistry, it is a drug of choice to temporarily 
anesthetize the tiny nerve endings located on the surfaces of the oral 
mucosa. As a local anesthetic, lidocaine is characterized by a rapid 
onset of action and intermediate duration of efficacy, making it suitable 
for infiltration and nerve block anesthesia. Lidocaine stabilizes the 
neuronal membrane by inhibiting the ionic fluxes required for the 
initiation and conduction of impulses, thereby effecting local anesthetic 
action [13].
There are several pharmaceutical dosage forms of lidocaine HCL 
available in the market such as solution for injection or infusion, nasal 
spray, oral gel, and transdermal patches [14,15].
In previous literatures, no attempt has been taken to formulate lidocaine 
HCL as buccal in situ gel spray. In the present study, a pH-triggered 
in situ gel as a buccal drug delivery system was developed. The gel 
system is to be made from polymers that exhibit phase transition due 
to physicochemical change in the environment. This gel system can 
be conveniently sprayed as a solution into the buccal mucous, and on 
contact with the saliva, the system changes its conformation to form a 
gel. This delivery system can provide the ease of administration to the 
patient similar to spray solution and can also provide a long retention 
time for the longer duration of action because of the gel formation.
MATERIALS AND METHODS
Materials
Lidocaine HCL, xanthan gum, and propylparaben were supplied by 
Samarra Drug Industry as a gift. Carbopol 934 and 940 were purchased 
from HiMedia Laboratories Pvt, Ltd., Mumbai, India. All other chemicals 
and solvents were of analytical reagent grade, and deionized water was 
used in this study.
Method
Selection of polymer
In this work, two grades of carbopol were used (carbopol 934 and 
carbopol 940) as in situ gelling polymers. It was found that mixing 
carbopol (either grade) with Lidocaine HCL leads to the formation of a 
precipitate. Therefore, it was decided to add other polymers to prevent 
the formation of the precipitate and helps improve the stability of the 
preparations.
The investigated polymers were each of hydroxyl propyl methyl cellulose, 
xanthan gum, sodium carboxymethyl cellulose, sodium alginate, and 
guar gum. Each of these polymers was tested separately in combination 
with carbopol and lidocaine HCl solution to achieve the best polymer 
combination for the formulation of the intended in situ gel.
Preparation of pH-induced in situ gel
Eight formulations were designed as shown in Table 1 using various 
concentrations of carbopol 934 and 940 (0.1, 0.3, 0.5, and 0.7% w/v) in 
combination with 0.2% (w/v) xanthan gum.
Carbopol and xanthan gum were dispersed in a beaker containing 
purified water and kept refrigerated at 4°C overnight to allow 
hydration. On the other hand, lidocaine HCl was dissolved in phosphate 
buffer pH 6.8. Propylparaben was added to the resulting drug solution. 
The drug solution was then added to polymer solution with constant 
stirring using electrical stirrer until a uniform solution was obtained. 
The volume of the final solution was brought up to 100 ml using 
deionized water [16].
Evaluation parameter
Visual appearance and clarity
Visual appearance and clarity of the prepared solution were checked for 
the presence of any particulate matter using fluorescent light against a 
white and black background.
pH of the formulation
The pH of the developed formulations was evaluated using a digital pH 
meter. The pH probe was immersed in the formulation for 5 min, and 
then, the readings were recorded.
Content uniformity
The drug content of the prepared in situ gel was determined by placing 
1 ml of formulation liquid in 100 ml volumetric flask. The volume was 
made up to 100 ml by adding phosphate buffer pH 6.8 to the flask. 
Subsequently, a volume of 4ml of the diluted solution was taken out 
into a 10ml volumetric flask and the volume was adjusted with pH 6.8 
phosphate buffer [17].
Absorbance was measured using double-beam ultraviolet (UV) 
spectrophotometer at 272 nm [18]. The amount of drug present was 
calculated using calibration curve.
Gelling capacity (sol-to-gel transition/in vitro)
All prepared formulations were evaluated for gelling capacity to 
identify the composition suitable for use as in situ gelling system. The 
gelling capacity test was implemented by placing a drop of each formula 
in a 10-ml beaker containing 5-ml phosphate buffer and equilibrated at 
37°C. Visual assessment of the gel as it forms time for gelation as well 
as time taken for the gel formed to dissolve was monitored during this 
test [19].
Syringeability
All prepared formulations were transferred into an identical 5-ml 
syringe placed with 20-gauge needle to a constant volume (1 ml). The 
solutions which were easily passed from syringe were termed as pass, 
while difficult to pass solutions were termed as fail [20].
Spray angle
The in situ gel sprays were actuated in horizontal direction onto a white 
paper mounted at a distance of 1 cm from the nozzle. The radius of the 
circle, formed on the paper, was recorded for minimum and maximum 







Where θ=spray angle in degree, l=the distance of paper from the nozzle, 
and r=average radius of circle.
Volume of solution delivered per each actuation
To determine the volume of prepared gel delivered per each actuation, 








Where AL is the volume of solution delivered per each actuation,
Wt is weight of formulation after actuation,
W0 is initial weight of formulation before actuation, and
Da is the density of the formulation
Rheological studies
Rheological properties of the prepared in situ gelling systems under 
different shear rates (6, 12, 20, 30, and 60 rpm) were determined at non-
physiological (pH 4.5–5.8 and 25°C) and physiological (pH 6.8 and 37°C) 
conditions, respectively, using digital viscometer with spindle number 
3. The viscosity of the samples was recorded before and after gelation.
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In vitro release study
The in vitro release study of lidocaine HCl was carried out using a 
modified dissolution apparatus Type II (paddle type). 1 ml of each 
formulation was placed in a dialysis membrane (0.08 µm pore size) 
which was previously soaked in phosphate buffer pH 6.8. The dialysis 
membrane is tied to the paddle shaft and immersed in 150 ml phosphate 
buffer pH 6.8 as a dissolution media rotated at 50 rpm and maintained 
at 37±1°C [22].
Samples of 5 ml were withdrawn at specific time interval and replaced 
with equal volume of fresh media. The samples were analyzed for drug 
concentration using UV visible spectrophotometer at 272 nm.
Analysis of release mechanism
The release kinetics of lidocaine HCl from in situ gel formulation was 
evaluated considering four different models including zero order, first 
order, Higuchi model, and Korsmeyer–Peppas model using a Microsoft 
Excel plug-in program DD Solver [23].
Dissolution profile comparison
The similarities between two in vitro dissolution profiles were assessed 
by pair-wise independent model procedures named as similarity factor 
(f2). For similar release profiles, the similarity factor should be in the 
range of 50–100 (closer to 100) [24].
The similarity factor is a logarithmic reciprocal square root 
transformation of the sum of squared error and is a measurement of 
the similarity in the percentage of the dissolution between two curves:
−
=












Where n is the sampling number, and Rt and Tt are the percentage 
of dissolved reference and test product at each time point t, 
respectively [25].
Statistical analysis
All experiments were run in triplicates. The obtained results were 
expressed as mean±standard deviation (SD). Analysis of variance test 
was used to determine the significance. The results were considered 
statistically significant at p<0.05.
RESULTS AND DISCUSSION
Selection of polymer combination
First, formulation containing carbopol alone was prepared. As observed 
during practical work that carbopol solution with lower concentration 
has low viscosity whereas at higher concentration, the viscosity was 
very high. However, the concentration of carbopol required to form stiff 
gel results in highly acidic solutions, which are not easily neutralized by 
the buffering action of the saliva.
Another problem was encountered that carbopol was precipitated on 
the addition of drug solution and this finding was also observed by Patil 
et al. when norfloxacin solution was added to carbopol solution [26]. It 
was stated previously that carbopol gel viscosity is dependent on the 
presence of electrolytes and the pH, and generally, a maximum of 3% 
electrolytes can be added before a rubbery mass forms [27]. Therefore, 
to decrease the concentration of carbopol without compromising 
gelling capacity and rheological properties and improving the stability 
of the prepared gel, it was decided to use a viscosity increasing agent.
Hydroxypropyl methylcellulose, xanthan gum, sodium carboxy 
methylcellulose, sodium alginate, and guar gum were tested separately 
with carbopol and drug solution. It was found that xanthan gum formed 
the most stable dispersion with carbopol and drug solution without 
precipitation which can be explained by synergistic interaction takes 
place between xanthan gum and hydrocolloid, especially in the presence 
of salt, which is necessary for optimum functionality and stability of 
xanthan gum [28].
Preparation of in situ gel
Carbopol solutions of 0.1, 0.3, 0.5, and 0.7% (w/v) retained liquid state 
(free flow) at pH range (4–5.8) and at 25°C and gelled on exposure to 
physiological conditions (pH 6.8 at 37°C). Different concentrations 
of xanthan gum were tested 0.1%–0.4% (w/v) to optimize the 
concentration suitable for in situ gel formulation. The optimum 
concentration of xanthan gum selected was 0.2% (w/v). Xanthan gum 
concentration above 0.2% (w/v) forms gel at formulation condition, so 
it can no longer be used.
Evaluation parameter
Visual appearance and pH
All the prepared in situ gelling systems were evaluated for visual 
appearance, clarity, and pH as shown in Table 2. It was observed that, 
as carbopol concentration increases, the pH of the formulation becomes 
acidic due to the acidic nature of the polymer. The solution becomes 
translucent at pH 4, while at pH 5, it was clear. These findings were 
also observed in the preparation of pH-induced in situ gelling system of 
lomefloxacin HCl [29].
Content uniformity
The drug content of the buccal formulations of lidocaine HCl in situ 
gel was found to be satisfactory ranging between 98.20%±0.04 and 
99.10%±0.03, indicating uniform distribution of the drug throughout 
the formula.
Gelling capacity (sol-to-gel transition/in vitro)
From the physical appearance, it seems that formulation containing 
0.1%–0.3% (w/v) carbopol had free-flowing properties at non-
physiological pHs. On the other hand, for carbopol concentration equal 
to 0.3% (w/v) (F2 and F6), a harder gel having higher gelation capacity 
was formed at physiological pH compared to 0.1% (w/v) carbopol 
containing formulations (F1 and F5). Most of the formulations have 
shown an instantaneous gelation (<20 s). Among the others (F4 and F8), 
the time required for complete gelation was 2–4 min.
As the concentration of carbopol was increased (0.5 and 0.7% w/v), the 
solution became more acidic and it cannot be neutralized by buffering 











Propylparaben Deionizedwater q. s
F1 5 0.1 – 0.2 0.02 100
F2 5 0.3 – 0.2 0.02 100
F3 5 0.5 – 0.2 0.02 100
F4 5 0.7 – 0.2 0.02 100
F5 5 – 0.1 0.2 0.02 100
F6 5 – 0.3 0.2 0.02 100
F7 5 – 0.5 0.2 0.02 100
F8 5 – 0.7 0.2 0.02 100
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action of salivary pH, and thin gel was formed at physiological pH 
(Table 2).
Similar results were obtained by Nandgude et al. who studied the 
formulation of pH-induced in situ nasal gel of salbutamol sulfate in 
that, as carbopol concentration was increased, the solution cannot be 
neutralized by nasal pH [30].
Syringeability
Syringeability of the formulations was determined as per material and 
concentration. Syringeability of all the formulations is shown in Table 3.
All the formulations were passed freely through the used syringe 
needle.
Spray angle
The results of spray angle are shown in Table 3. The spray angle was 
found to be significantly increased (p<0.05) in the range of 25.7°±0.3–
42°±0.1 as the volume per each actuation increased and the viscosity 
decreased for either polymer grade. The same results of spray angle 
were obtained for oral cavity sprays containing herbal extracts [31].
Volume per each actuation
The average amount of the product delivered from spray devices 
was 0.11±0.011–0.15±0.023 ml, and the volume deviation could be 
attributed to formulation compositions and concentration.
Rheological study
Viscosity of formulations was measured as the change of shear rate under 
non-physiological and physiological conditions to investigate the rheology 
of these formulations. Figs. 1 and 2 show the rheological profile of the 
formulations at physiological and non-physiological pH, respectively.
To apply easily at the affected site, the formulation must possess 
optimum viscosity. Furthermore, the formulation should undergo rapid 
sol-to-gel transition on contact with the affected site. It was found that, 
as the shear rate increased, the viscosity of gel decreased indicating 
shear thinning pseudoplastic flow property [32].
At pH of the preparation listed previously in Table 2, the formulations 
were in a liquid state and exhibited low viscosity. An increase in the pH 
to 6.8 caused the solutions to transform into gels with high viscosity.
The viscosity of the formulations was found to be influenced by the 
concentration of polymers used; hence, a significant increase (p<0.05) 
in viscosity was observed with increasing polymer concentrations. This 
may be due to higher degree of cross-linking at higher concentrations 
of polymers [33].
Using different polymer grades resulted in a significant increase in 
viscosity (p<0.05). Formulations containing carbopol 940 (F5-F8) 
exhibited higher viscosity than formulations containing carbopol 934 
(F1-F4) at the same concentration. Different rheological properties and 
viscosity values between the two grades are mainly reflected by the 
polymer particle size, molecular weight between cross-links, allocation 
of molecular crosslinks, and the fraction of the overall units that arise as 
terminal units, i.e., free chain ends [34].
In vitro release study
Graphical representations of release profile for in situ gels regarding 
the effect of polymer concentration are shown in Figs. 3 and 4 using 
carbopol 934 and 940, respectively.
The results indicated that, as the concentration of carbopol increases, 
the release of drug decreases. F4 and F8 with 0.7% carbopol 934 and 
940 have slowest release profile. The results of t80% (time required for 
80% of drug to be released) are shown in Table 4.
Table 2: pH values and physical appearance of the prepared 
in situ gels
Formulation code pH Physical appearance
F1 5.8±0.03 Thin transparent liquid
F2 5.07±0.02 Thin transparent liquid
F3 4.8±0.01 Translucent dispersion
F4 4.05±0.01 Opaque dispersion
F5 5.8±0.03 Thin transparent liquid
F6 5.2±0.02 Transparent dispersion
F7 4.7±0.02 Translucent liquid dispersion
F8 4.5±0.02 Translucent dispersion
All the values are in mean±SD, (n=3). SD: Standard deviation
Table 3: Volume per each actuation, spray angle, and 









F1 0.14±0.012 42°±0.1 Pass +++
F2 0.13±0.022 39°±0.3 Pass ++++
F3 0.12±0.013 33.3°±0.2 Pass ++
F4 0.11±0.011 28.7°±0.5 Pass +
F5 0.15±0.023 38.6°±0.1 Pass +++
F6 0.14±0.030 32.8°±0.4 Pass ++++
F7 0.13±0.023 28.3°±0.3 Pass ++
F8 0.12±0.013 25.7°±0.3 Pass +
All the values are in mean±SD (n=3). **Where: +: Gel slowly, remain for 5 min, 
++: Immediate gelation, remain for several minutes, +++: Immediate gelation 
but for few extended periods, ++++: Immediate gelation, harder gel but for 
more extended periods. SD: Standard deviation
Fig. 1: The viscosity of in situ gel at non-physiological pH (before 
gelation), (mean±standard deviation, n=3)
Fig. 2: The viscosity of in situ gel at physiological pH (after 
gelation), (mean±standard deviation, n=3)
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A significant increase in t80% was observed as the concentration of 
polymer increases.
The above results can be explained by rheological studies where the 
rate of drug release decreases as the viscosity of the in situ gel increases 
due to the presence of higher concentration of polymer, resulting in this 
retardation effect [35,36].
Figs. 5 and 6 show the effect of polymer grade on the dissolution profile. 
It seems that in situ gels formulated with carbopol 940 have longer 
dissolution profile in comparison with carbopol 934-based in situ gels 
at the same concentration.
This is also consistent with the rheological study as shown in Fig. 2, in 
which formulas F5, F6, F7, and F8 based on carbopol 940 have higher 
viscosity compared to F1, F2, F3, and F4 based on carbopol 934.
In vitro release of drug from formulation and gelation studies indicates 
that F2 containing 0.3% carbopol 934 and xanthan gum 0.2% was 
considered as an optimized formulation, in which 80% of drug is 
released within 45 min and might provide an effective painless 
anesthetic effect during dental treatment.
Dissolution profile comparison
The in vitro similarity factor f2 was assessed to compare the dissolution 
profile of the prepared formulations to investigate the effect of 
increasing polymer concentration as well as the effect of using different 
carbopol grades on the release properties.
The results of dissolution profile comparison indicated that the 
dissolution profile of F1 is different from F2, F3, and F4 profiles. 
F5 does not resemble F6, F7, and F8 as well as F7 and F8 have 
non-equivalent profiles as shown in Table 5. This indicates that 
Fig. 3: Effect of carbopol 934 concentration on the release profile 
of F1, F2, F3, and F4 in phosphate buffer pH 6.8 at 37°C, (mean ± 
standard deviation, n=3)
Fig. 4: Effect of carbopol 940 concentration on the release 
profile of F5, F6, F7, and F8 in phosphate buffer pH 6.8 at 37°C, 
(mean±standard deviation, n=3)
Fig. 5: Effect of polymer grade on the release profile of F1, F5, 
F2, and F6 in phosphate buffer pH 6.8 at 37°C, (mean±standard 
deviation, n=3)
Fig. 6: Effect of polymer grade on the release profile of F3, F7, 
F4, and F8 in phosphate buffer pH 6.8 at 37°C, (mean±standard 
deviation, n=3)
Table 4: t80% values









t80% is the time required for 80% of drug to be released. All the values are in 
mean±SD, (n=3). SD: Standard deviation
Table 5: Values of similarity factor ƒ2 for the release profile in 
phosphate buffer pH 6.8
Formulation# F2 F3 F4 F5 F6 F7 F8
F1 47.5 37 15.3 31.8 - -
F2 - 51.2 - - 40.8 - -
F3 - - 26.1 - - 44.3 -
F4 - - - - - - 46.9
F5 - - - - 40.3 40.8 54.6
F6 - - - - - 54.6 -18.1
F7 - - - - - 29.5
The use of different polymer grade, carbopol 934 and carbopol 940, resulted in 
non-equivalent dissolution profile at the same concentration where f2 value is 
<50
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increasing polymer concentration resulted in different dissolution 
profiles.
F2 and F3 as well as F6 and F7 are likely to possess similar dissolution 
characteristics since f2 is between 50 and 100, and this means that 
increasing the concentration for these batches does not have a 
considerable effect on dissolution profile [37].
The use of different polymer grade, carbopol 934 and carbopol 940, 
resulted in non-equivalent dissolution profile at the same concentration 
where f2 value is <50.
F1 (0.1% carbopol 934) has different dissolution profiles from F5 (0.1% 
carbopol 940), F2 (0.3% carbopol 934) is different from F6 (0.3% carbopol 
940), F3 (0.5% carbopol 934) is different from F7 (0.5% carbopol 940), 
and F4 (0.7% carbopol 934) is different from F8 (0.7% carbopol 940).
This suggested that using different polymer grade resulted in 
considerable effect on the dissolution profile.
Analysis of release mechanism
The highest correlation coefficient (R2) was obtained with Korsmeyer–
Peppas model for all formulations but combined with zero order in case 
of F8 which indicates that the drug release is ruled by both diffusions of 
the drug and dissolution/erosion of the gel matrix [38].
The release exponent (n) for all the formulations was in the range of 
0.17–0.82 as shown in Table 6. If n value has the limiting values of 0.45 
or less, the release mechanism follows Fickian diffusion and higher 
values of 0.45–0.89 for mass transfer follow a non-Fickian model or 
anomalous mechanism of drug release.
The drug release follows zero-order drug release and Case II transport 
if the n value is 0.89. For the values of n higher than 0.89, the mechanism 
of drug release is regarded as super Case II transport (relaxation) [39].
The drug diffusion through most types of polymeric systems is often 
best described by Fickian diffusion, but there might be also a relaxation 
of the polymer chains, which influences the drug release mechanism. 
This process is described as non-Fickian or anomalous diffusion. 
The observed deviation from Fickian mechanism, represented by F4 
and F8, can be attributed to the reason that the formulations during 
gelation usually imbibe a large amount of dissolution fluid leading to a 
swollen state of the gel. This might have resulted in the polymeric chain 
relaxation, resulting in non-Fickian mechanism [40].











K0 R2 K1 R2 KH R2 kKp R2 N
F1 2.82 0.07 0.13 0.93 17.1 0.82 46.2 0.99 0.17
F2 1.14 –0.5 0.08 0.82 11.1 0.64 39.2 0.99 0.18
F3 0.92 –0.6 0.04 0.66 10.6 0.76 29.4 0.99 0.24
F4 0.67 0.91 0.01 0.95 6.6 0.97 5.5 0.99 0.53
F5 1.1 0.09 0.04 0.89 10.3 0.87 21.5 0.99 0.34
F6 0.86 0.08 0.03 0.77 8.9 0.82 24.7 0.97 0.25
F7 0.72 0.34 0.02 0.7 7.8 0.86 19.2 0.98 0.29
F8 0.55 0.99 0.01 0.97 5.5 0.89 1.2 0.99 0.82
K0, K1, KH, and kKp are the release constants for zero, first, Higuchi, and 
Korsmeyer–Peppas model, n is the release index for Korsmeyer–Peppas
CONCLUSION
Lidocaine HCl was successfully formulated in a pH-triggered in situ 
gelling system using carbopol 934 in combination with xanthan gum. 
Applying of the in situ gel using spray tool regarded as a newer approach 
to improve easy dental application.
The developed formulation (F2) shows satisfactory results for 
gelling capacity, pH, syringeability, release profile, and other physical 
properties.
It had been shown that increasing polymer concentration for both 
carbopol grades resulted in different dissolution profile when similarity 
factor ƒ2 is applied. Furthermore, different dissolution profiles were 
obtained using the same concentration but different polymer grades.
The in situ gelling system delivered as a spray will most probably get 
good acceptance by patients and health-care professionals because 
it is easy to apply and gradually erodes by dissolution of the gel also 
avoiding the need for removal. It can be concluded that lidocaine HCl 
in situ gel spray is a viable alternative to conventional oral gel as well as 
avoidance of needle usage.
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